KRTL Biotech Acquires Majority Stake in Nutrivance Global

Lakewood-based KRTL Holding Group Inc. (OTC: KRTL) announced that its wholly owned subsidiary, KRTL Biotech Inc., has acquired a 55% majority equity stake in Skidmore Companies LLC, now operating as Nutrivance Global. This acquisition aims to expand KRTL’s distribution of Active Pharmaceutical Ingredients (APIs) through Nutrivance Global’s established government and private networks.

A strategic aspect of the acquisition includes a sophisticated data platform that facilitates real-world decision-making. This capability allows Nutrivance Global to provide actionable insights, enhancing its ability to support efficient API deployment across its networks.

The partnership aims to improve the distribution of KRTL’s API portfolio while increasing access to FDA-approved food and beverage products and cosmetic lines for international markets. By integrating Nutrivance Global’s financial operations and establishing a revenue-sharing structure, the collaboration seeks to enhance management transparency and leverage distribution channels.

Nutrivance Global’s expertise in API distribution and its developed networks will bolster KRTL’s infrastructure, improving supply chain efficiency and regulatory compliance. The partnership is positioned to meet the rising global demand for APIs and other advanced solutions while encouraging innovation and market expansion.

“This partnership underscores the mutual strengths of KRTL and Nutrivance Global,” said Cesar Herrera, CEO of KRTL Holding Group. “With Nutrivance’s distribution network and innovative data platform paired with our extensive API portfolio, we are creating a collaborative path toward sustainable growth in global markets.”

Kim Skidmore, CEO of Nutrivance Global, added, “This transition is an exciting phase for our company. Partnering with KRTL enables us to innovate, scale operations, and deliver reliable APIs and premium cosmetic products to global consumers.”

This partnership marks a significant step in KRTL’s strategy to strengthen its footprint in API distribution and real-world data-driven decision-making. KRTL Biotech and Nutrivance Global are focused on delivering reliable solutions that respond to the changing needs of the healthcare and beauty industries.

Source

Related